PrimeRFP SCOUT · Federal Contract Recompete Brief

75N93022C00057Advanced development of a vaccine candidate — Immunartes LLC

Immunartes LLC holds $4.2M across 1 federal awards, concentrated at Department of Health and Human Services (HHS). Competition previously drew 10 offers. Set-aside status: NONE. Recompete timing centers on the Apr 30, 2027 PoP end — agencies typically plan 12–18 months ahead.

National Institutes Of Health Niaid

Awarding office

Immunartes LLC

Recipient

Apr 30, 2027

PoP end

$5.4M

Obligated

$12.1M

Potential

541715

NAICS

AN12

PSC

NONE

Set-aside

10 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Score my position vs Immunartes LLC — $90

Contract facts

NONE

Contract number75N93022C00057

AgencyNational Institutes Of Health Niaid

Awarding officeNational Institutes Of Health Niaid

Awarding agencyDepartment of Health and Human Services (HHS)

Funding agencyDepartment of Health and Human Services (HHS)

IncumbentImmunartes LLC

CAGE82S33

UEIETMGB9KR3GG4

NAICS541715

PSCAN12

Place of performanceCHICAGO IL

Pricing typeCost Plus Fixed Fee

Extent competedFull And Open Competition

Related solicitation2021-1

PoP startSep 21, 2022

PoP end (current)Apr 30, 2027

Obligated$5.4M

Current value$5.4M

Potential value$12.1M

ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION AND COLONIZATION. is a federal NONE award for National Institutes Of Health Niaid held by Immunartes LLC. Estimated value $12.1M ($5.4M obligated). Current period of performance ends Apr 30, 2027. Last award drew 10 bidders. Place of performance: CHICAGO IL. Related solicitation 2021-1.

ADVANCED DEVELOPMENT OF A VACCINE CANDIDATE FOR STAPHYLOCOCCUS AUREUS INFECTION AND COLONIZATION.

Recompete timing

Public

● Expiring in 235 days

Current PoP ends Apr 30, 2027 (235 days remaining). Agencies typically plan 12–18 months ahead — at 7.7 months out, that window is already open. The buying decision is likely already in motion.

Incumbent footprint

Public record

Immunartes LLC — $4.2M obligated across 1 awards (firm-wide, all agencies).

Sole agency: Department of Health and Human Services (HHS)

Department of Health and Human Services (HHS)$4.2M · 100% of firm total

Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 75N93022C00057?

75N93022C00057 (Advanced development of a vaccine candidate) is a National Institutes Of Health Niaid award with a potential value of $12.1M, currently held by Immunartes LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75N93022C00057?

National Institutes Of Health Niaid awarded 75N93022C00057 to Immunartes LLC (potential $12.1M).

Who is the incumbent on 75N93022C00057?

Immunartes LLC is the incumbent with $4.2M across 1 related awards in SCOUT’s public footprint. The current period of performance ends Apr 30, 2027.

When does Immunartes LLC’s 75N93022C00057 come up for recompete?

SCOUT tracks a period-of-performance end of Apr 30, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Seen enough? Run one full capture cycle on 75N93022C00057 — $90 for 90 days.

This page stays free. Pilot is the live layer: displacement scoring, recompete pipeline, Daily Brief, and SCOUT MCP for 90 days. If you already live in Claude or ChatGPT and only need live search, start MCP Explorer at $29/mo.

Start Pilot — $90

$1/day · one payment · no subscription

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Aug 19, 2026 · refreshed monthlyLatest procurement action Jul 22, 2026